Results 181 to 190 of about 13,898 (220)

Biglycan promotes tumour proliferation and invasion in human colon cancers. [PDF]

J Int Med Res
Lu B, Zhu Y, Li G, Xu Y, Wen C, Ye W.
europepmc   +1 more source

シコンマク　トクイテキ　ブンシ　PLAP-1　ニ　ヨル　TLR2　オヨビ　TLR４　ヲ　カイシタ　メンエキ　オウトウ　セイギョ　キコウ [PDF]

ヤマバ, サトコ, 山羽, 聡子
core   +1 more source

Development of a 3D tumor model based on decellularized matrix using high-throughput approaches. [PDF]

Front Bioeng Biotechnol
Siahmansouri H, Fenoglio D, Filaci G, Mastrogiacomo M.   +3 more
europepmc   +1 more source

Decorin and/or biglycan knockdown in aged mouse patellar tendon impacts fibril morphology, scar area, and mechanical properties. [PDF]

J Orthop Res
Newton JB, Weiss SN, Nuss CA, Darrieutort-Laffite C, Eekhoff JD, Birk DE, Soslowsky LJ.   +6 more
europepmc   +1 more source

Alterations in Immunomodulatory Potential of ADSCs Undergoing Osteogenic Differentiation in the Context of Future Therapeutic Applications. [PDF]

Cells
Szabłowska-Gadomska I, Rudziński S, Mroczko A, Mrozikiewicz-Rakowska B, Cysewski D, Gasperowicz P, Bocian K.   +6 more
europepmc   +1 more source

Diagnostic potential of blood-based biomarkers in multiple sclerosis. [PDF]

Front Neurol
Holm Nielsen S, Karsdal M, Manoel B, Bay-Jensen AC, Henriksen K.   +4 more
europepmc   +1 more source

GLIS2 Promotes Epithelial-Mesenchymal Transition and Gastric Cancer Progression by Regulating BGN to Activate the Wnt/β-Catenin Pathway. [PDF]

Kaohsiung J Med Sci
Yan J, Deng YP.
europepmc   +1 more source

Golgins support extracellular matrix secretion by collectively maintaining the Golgi structure-function relationship

Thompson G, Hoyle A, Lewis PA, Esther Prada-Sanchez M, Swift J, Heesom K, Lowe M, Stephens D, Stevenson N.   +8 more
europepmc   +1 more source

Biglycan Deficiency Interferes With Ovariectomy-Induced Bone Loss [PDF]

Journal of Bone and Mineral Research, 2003
Abstract Biglycan is a matrix proteoglycan with a possible role in bone turnover. In a 4-week study with sham-operated or OVX biglycan-deficient or wildtype mice, we show that biglycan-deficient mice are resistant to OVX-induced trabecular bone loss and that there is a gender difference in the response to biglycan deficiency.
Matthew Allen, Susan A Bloomfield, Thomas Levin Andersen   +2 more
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Biglycan: A regulator of hepatorenal inflammation and autophagy

Matrix Biology, 2021
Soluble biglycan, a small leucine-rich proteoglycan, plays a significant role in several pathologies as it has emerged as an extracellular matrix-derived danger-associated molecular pattern. Biglycan is released from the extracellular matrix in response to tissue injury and, as a canonical danger signal, interacts with innate immune receptors, Toll ...
Martin Schulz, Jonel Trebicka, Małgorzata Wygrecka   +2 more
exaly   +3 more sources